Blocking NDRG1 in old mice made aging muscle stem cells behave more like young ones, boosting activation and improving repair after injury.
NDRG1 levels were 3.5 times higher in older stem cells, where the protein suppressed the mTOR pathway that normally drives cell activation and growth.
The same protein also helped aged stem cells survive longer under stress; when researchers turned it off, fewer cells remained alive over time and regeneration worsened after repeated injuries.
UCLA researchers said the finding points to a cellular “survivorship bias,” in which aging leaves behind slower but hardier stem cells, a trade-off that could shape future therapies for muscle repair.
Is the slow healing of aging muscles a sign of failure or a clever survival strategy?
If a 'brake' on muscle repair also ensures long-term survival, can we safely disable it?
How NDRG1 Shapes the Trade-Off Between Muscle Regeneration and Stem Cell Longevity in Aging
Overview
Groundbreaking research from UCLA reveals that as muscle stem cells age, they accumulate more of the protein NDRG1, which acts as a brake on the mTOR pathway—a key regulator of cell growth and repair. This slowdown in the mTOR pathway leads to slower muscle repair in older individuals. The study highlights an evolutionary trade-off: while younger muscle stem cells repair quickly, aged cells prioritize long-term survival over rapid regeneration. Understanding how NDRG1 balances repair and survival opens new possibilities for therapies to improve muscle regeneration in aging, while emphasizing the need to protect the stem cell pool for lasting health.